APONTIS PHARMA AG

Highlights Apontis Pharma AG Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Real-time Estimate Tradegate Other stock markets 05:48:10 14/05/2024 pm IST			5-day change	1st Jan Change
8.77 ^EUR	-2.77%		+6.68%	+84.19%

05/04	Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	MT
28/03	Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	05/04	MT
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Apontis Pharma Provides Earnings Guidance for the Full Year 2023	09/11	CI
Apontis Pharma AG Reports Earnings Results for the Half Year Ended June 30, 2023	11/23/11	CI
AstraZeneca Cancels Lung Disease Drug Co-promotion Deal With Apontis Pharma	01/23/01	MT
Aontis Pharma AG Launches Single Pill Finder and Distribution of Single Pill Rosazimib	29/23/29	CI
APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills	09/23/09	EQ
Apontis Pharma Ag Provides Revenue Guidance for the Year 2023	03/23/03	CI
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations	09/23/09	EQ
Apontis Pharma In-Licenses Single Pill for Hypertension, Hyperlipidemia Treatment	31/23/31	MT
APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensing a new Single Pill	31/23/31	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW